Clinical Trial Update: Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

View source ↗

Summary

This completed clinical trial reports on the duration of suppression of bone turnover after treatment with zoledronic acid in men with metastatic castration-res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Castration-resistant Prostate Cancer

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Metastatic Prostate Cancer, Bone Metastasis | Status: COMPLETED